Supplementary Figures 1-5 and Table S1 from Platelet-Coated Circulating Tumor Cells Are a Predictive Biomarker in Patients with Metastatic Castrate-Resistant Prostate Cancer

Abstract

<p>S1. Platelet confirmation with CD61 staining in the SKBR3-spiked NBD sample S2. Enumeration of CTC subtypes S3. Survival analysis using AVPC-MS-CTC status S4. Survival analysis in patients without pc.CTC S5. Treatment decision tree Table S1. Correlation between CTC and clinical characteristics</p>